Guidelines

Highlights of the EHA

October 2015
Highlights of the 13 International Conference on Malignant Lymphoma

October 2015
Monitoring deep response in chronic myeloid leukaemia: new methodologies and innovative technologies

September 2015
Optimizing patient outcomes in CML

September 2015
When is ponatinib a suitable treatment option for patients with chronic phase CML and how can we optimize the benefit/risk ratio?

September 2015
Inotuzumab ozogamicin (InO) shows promising efficacy and safety in ALL

September 2015
Blinatumomab: new hope for patients with relapsed/refractory acute lymphoblastic leukemia

September 2015
Driver mutations and their evolution in CLL

September 2015
Venetoclax-rituximab induces deep responses in relapsed CLL

September 2015
Advances in Acute Myeloid Leukaemia: Increased insights in chemoresistance and first randomised evidence for kinase inhibition

September 2015

Top